Get started
Author

Cole R. Scholtz

Observed name: Cole R. Scholtz
ORCID: 0000-0002-3654-5075
Observed ORCID: 0000-0002-3654-5075
OpenAlex ID: A5085764281
A Structure-based Design Approach for Generating High Affinity BRD4 D1-Selective Chemical Probes
2022 · Huarui Cui, Anand Divakaran, et al. · Journal of Medicinal Chemistry · 38
Development of an N-Terminal BRD4 Bromodomain-Targeted Degrader
2022 · Anand Divakaran, Cole R. Scholtz, et al. · ACS Medicinal Chemistry Letters · 19
PDF
Efficacy and Toxicity Analysis of Selective BET Bromodomain Inhibitors in Models of Inflammatory Liver Disease
2025 · Luke C. Doskey, Cole R. Scholtz, et al. · Journal of Medicinal Chemistry · 7
Exploration of surface chemistry effects on the biodistribution and pharmacokinetics of dual-ligand luminescent gold nanoparticles
2023 · Yueqiu Lin, Shanghai Yong, et al. · Colloids and Surfaces A Physicochemical and Engineering Aspects · 4
Development of cell-active BRD4-D1 selective inhibitors to decode the role of BET proteins in LPS-mediated liver inflammation
2025 · Cole R. Scholtz, Luke C. Doskey, et al. · European Journal of Medicinal Chemistry · 3
Stranger Rings: How Heteroarenes and the Degree of Methyl Group Fluorination Affect Photolysis Kinetics and Fluorinated Product Formation
2025 · Thomas F. Mundhenke, Mattia G. Balestra, et al. · Environmental Science & Technology · 3
Design of Tissue-Selective PROTACs Through Recruiting E3 Ligase Scaffolding Protein MAGEA11
2025 · Isabella E. Jacobsen, Rui Shi, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
BET Bromodomain Pan-D1-Biased Inhibitors with Improved Drug-Like Properties and hERG Profiles as Therapies for Inflammatory Liver Injury
2026 · Nora R. Vail, Luke C. Doskey, et al. · ChemRxiv
Eyes Toward the Clinic: Selective Inhibition and Degradation Approaches to Bromodomain‐Containing Proteins
2026 · Cole R. Scholtz, William C. K. Pomerantz · ChemBioChem
Development of Cell-Active BRD4-D1 Selective Inhibitors to Decode the Role of BET Proteins in LPS-Mediated Liver Inflammation
2025 · William Pomerantz, Cole R. Scholtz, et al. · SSRN Electronic Journal
Works count: 10
Citation count: 75
H-index: 4
I10-index: 2
Year
Topic
Type